Abstract

Since the beginning of the 1990s, increasing evidence supports beneficial effects of nut consumption on health. A new analysis of the Spanish PREDIMED trial, published in BMC Medicine, has expanded our knowledge. The study showed that individuals eating nuts more than three times per week died less often from cardiovascular disease and cancer than non-consumers. The study also adds an important finding that previous epidemiological studies could not provide: a protective effect on premature mortality was only seen in the intervention group in which nut consumption increased during the 4.8 years of follow-up, not in the intervention group with additional olive oil consumption or in the control group. Nut consumption actually decreased during follow-up in the latter two groups. Questions remain to be answered on the quantity of nuts to be consumed for health benefits, on possible mechanisms of action, and on whether some types of nuts should be favored.Please see related research: http://www.biomedcentral.com/1741-7015/11/164.

Highlights

  • More than 20 years ago, the first studies were published on possible favorable effects of nut consumption on health in the general population [1,2]

  • The study by Guasch-Ferré et al published in BMC Medicine which used information of the dietary intervention trial PREDIMED [4], provides additional convincing support for protective effects on cardiovascular disease and cancer mortality

  • Are walnuts healthy? The results of this study have shown an effect of any nut consumption on all outcomes [4]

Read more

Summary

Introduction

More than 20 years ago, the first studies were published on possible favorable effects of nut consumption on health in the general population [1,2]. Background More than 20 years ago, the first studies were published on possible favorable effects of nut consumption on health in the general population [1,2]. The study by Guasch-Ferré et al published in BMC Medicine which used information of the dietary intervention trial PREDIMED [4], provides additional convincing support for protective effects on cardiovascular disease and cancer mortality.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.